TRxADE HEALTH, Inc. Stock Price, News & Analysis

TRxADE HEALTH (NASDAQ: MEDS) recently announced a strategic partnership between its subsidiary Bonum Health and Coborn's, Inc. This agreement enables Bonum Health to provide affordable telemedicine services across Coborn's grocery stores in the Midwest, including Minnesota, Michigan, Wisconsin, and the Dakotas. The collaboration aims to enhance access to healthcare for uninsured and under-insured patients, offering cash discounts on medical encounters and prescription savings via Bonum's mobile app. This partnership is expected to improve healthcare delivery and affordability in the region.

TRxADE HEALTH (NASDAQ:MEDS) announced a joint venture with Exchange Health, LLC, forming SOSRx, LLC, aimed at creating a pharmaceutical platform to improve drug sales and distribution. SOSRx will help pharmaceutical manufacturers optimize inventory sales directly to large buyers, addressing the issue of short-dated and slow-moving drugs. This partnership is expected to enhance medication accessibility and cost-effectiveness for healthcare providers and patients.

TRxADE HEALTH (NASDAQ:MEDS) announced that CEO Suren Ajjarapu will present a company overview at the Aegis Capital Corp. Virtual Conference on February 24, 2022, at 1:30 PM Eastern. The conference runs from February 23 to 25, 2022, with presentations available by request. TRxADE focuses on optimizing the retail pharmacy experience through digital solutions and currently serves over 12,700 members nationwide. The presentation slides will be available on the TRxADE HEALTH website.

TRxADE HEALTH (NASDAQ:MEDS) has resumed its stock repurchase program, allowing for the buyback of up to 100,000 shares. Initially approved in May 2021, this program was paused due to an ongoing offering that has now been terminated. The repurchase will be funded using the company’s working capital, which stood at approximately $3.6 million as of September 30, 2021. The timing and volume of repurchases will depend on market conditions and other business factors.

TRxADE HEALTH, INC. (NASDAQ:MEDS) has launched its TRxADE Discount Card as part of the TrxadeHSO program, aimed at supporting independent pharmacies in offering lower drug prices while maintaining profit margins. The initiative, in partnership with Paramount Rx, connects over 12,950 independent pharmacy members to discounted pricing, ensuring price transparency and competitiveness with chain pharmacies. This program is expected to enhance patient care by improving access to affordable medications.

TRxADE HEALTH (NASDAQ:MEDS) announced its participation at the LD Micro Movers Virtual Event on December 1, 2021. CEO Suren Ajjarapu is set to deliver a 30-minute presentation at 5:00 p.m. Eastern Time. This event highlights notable small-cap companies and offers insights into TRxADE's focus on digitalizing the retail pharmacy experience by enhancing drug procurement and patient engagement. Interested parties can access the live audio webcast through the provided link, with an archived version available later.

TRxADE HEALTH (NASDAQ:MEDS) reported a 34.3% revenue increase for Q3 2021, totaling $2.6 million, up from $1.9 million in Q2 2021. However, revenue declined 58.7% year-over-year, down from $6.3 million due to non-recurring PPE sales in 2020. The gross profit improved to $1.3 million (50.2% margin) versus $1.9 million (30.5% margin) last year. Operating expenses rose to $2.6 million, leading to a net loss of $(1.3) million.

Cash and cash equivalents were $3.6 million at period end.

TRxADE HEALTH, INC (NASDAQ:MEDS) will announce its third quarter 2021 financial results after market close on October 25, 2021. A conference call to discuss the results will be held the same day at 5:00 p.m. Eastern time. The firm focuses on digitalizing the retail pharmacy experience, optimizing drug procurement, and patient engagement in the U.S. Currently, it operates a marketplace with over 12,700 members nationwide. A playback of the call will be available until November 25, 2021.

TRxADE HEALTH (NASDAQ:MEDS) will present at the LD Micro Main Event investor conference on October 12, 2021. The presentation, hosted by CEO Suren Ajjarapu, is scheduled for 1:30 PM ET and will focus on digitalizing the retail pharmacy experience. TRxADE operates a drug procurement marketplace with over 12,700 members and offers patient-centric telehealth services. A live webcast of the presentation will be available. For further details, visit the company's investor relations website.